Filariasis Treatment Market Share 2023 to 2033 | By AbbVie, Elsai, Cipla, Pfizer, Novartis AG
According to Future Market Insights, the global Filariasis Treatment Market demand will develop at a 10.1% compound annual growth rate (CAGR) between 2023 and 2033, reaching a value of US$ 28.68 billion by 2033. The rising prevalence of filariasis, enhanced diagnostic capabilities, and increased awareness of the dis...
Source: pharmiweb.com